DaVita
DVA
#1849
Rank
A$16.69 B
Marketcap
A$260.05
Share price
1.72%
Change (1 day)
31.34%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.57. In 2025 the company made an earnings per share (EPS) of A$14.32 a decrease over its 2024 EPS that were of A$15.61.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3914.48%
2025A$14.32-8.25%
2024A$15.6144.94%
2023A$10.7727.26%
2022A$8.46-35.56%
2021A$13.1344.1%
2020A$9.1119.7%
2019A$7.61540.48%
2018A$1.19-76.07%
2017A$4.97-19.31%
2016A$6.16242.52%
2015A$1.80-62.87%
2014A$4.8413.43%
2013A$4.278.45%
2012A$3.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$34.40 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$16.08 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$27.44 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.93-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA